We are live on ! Find out more
THRD

Third Harmonic Bio

Delisted

THRD was delisted on the 30th of July, 2025.

105 hedge funds and large institutions have $210M invested in Third Harmonic Bio in 2025 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 42 increasing their positions, 15 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

180% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 15

56% more capital invested

Capital invested by funds: $134M → $210M (+$75.7M)

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

27% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 22

6% more funds holding

Funds holding: 99105 (+6)

0.16% less ownership

Funds ownership: 85.93%85.77% (-0.16%)

46% less call options, than puts

Call options by funds: $367K | Put options by funds: $685K

Holders
105
Holders Change
+6
Holders Change %
+6.06%
% of All Funds
1.38%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.05%
New
28
Increased
42
Reduced
15
Closed
22
Calls
$367K
Puts
$685K
Net Calls
-$318K
Net Calls Change
-$525K
Name Holding Trade Value Shares
Change
Change in
Stake
LP
26
LMR Partners
United Kingdom
$1.09M +$997K +200,000 New
Northern Trust
27
Northern Trust
Illinois
$1.07M -$19.5K -3,904 -2%
Charles Schwab
28
Charles Schwab
California
$1.01M +$43K +8,632 +5%
Citadel Advisors
29
Citadel Advisors
Florida
$656K -$74.3K -14,904 -11%
FIA
30
FNY Investment Advisers
New York
$543K +$45.1K +9,048 +10%
Qube Research & Technologies (QRT)
31
Qube Research & Technologies (QRT)
United Kingdom
$527K -$311K -62,350 -39%
JP Morgan Chase
32
JP Morgan Chase
New York
$519K -$842K -168,877 -64%
Dimensional Fund Advisors
33
Dimensional Fund Advisors
Texas
$510K
PCM
34
Prelude Capital Management
New York
$417K +$34.5K +6,922 +10%
CSS
35
Cubist Systematic Strategies
Connecticut
$415K +$27.5K +5,512 +8%
Wellington Management Group
36
Wellington Management Group
Massachusetts
$411K +$377K +75,658 New
AQR Capital Management
37
AQR Capital Management
Connecticut
$400K +$258K +51,684 +235%
BNP Paribas Financial Markets
38
BNP Paribas Financial Markets
France
$399K -$180K -36,079 -33%
Millennium Management
39
Millennium Management
New York
$322K +$39.1K +7,832 +15%
Two Sigma Investments
40
Two Sigma Investments
New York
$319K +$53.9K +10,800 +22%
Barclays
41
Barclays
United Kingdom
$309K +$109K +21,874 +62%
Bank of New York Mellon
42
Bank of New York Mellon
New York
$290K +$37.1K +7,437 +16%
UBS Group
43
UBS Group
Switzerland
$284K +$20.4K +4,084 +8%
MAM
44
Martingale Asset Management
Massachusetts
$278K +$255K +51,113 New
Squarepoint
45
Squarepoint
New York
$277K -$353K -70,833 -58%
FLC
46
Fifth Lane Capital
Texas
$272K +$249K +50,000 New
SO
47
STRS Ohio
Ohio
$230K +$15K +3,000 +8%
TPC
48
Takeda Pharmaceutical Company
Japan
$200K
Susquehanna International Group
49
Susquehanna International Group
Pennsylvania
$193K +$36.9K +7,395 +26%
American Century Companies
50
American Century Companies
Missouri
$186K +$13.1K +2,632 +8%

THRD Hedge Fund Activity: Q2 2025 in Review

105 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Third Harmonic Bio (THRD) for Q2 2025, worth a combined $210M — up 56% from $134M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new THRD positions and 22 closed out — a net gain of 6 holders — while 42 added to existing stakes and 15 trimmed.

The largest buyer was Schonfeld Strategic Advisors, adding an estimated $3.69M. The largest seller was BVF Inc, exiting entirely with an estimated $8.23M sold.

  • 105 institutional investors held Third Harmonic Bio (THRD) as of Q2 2025, up from 99 in Q1 2025.
  • Funds reported $210M of Third Harmonic Bio stock for Q2 2025, up 56% quarter-over-quarter.
  • 28 funds opened new Third Harmonic Bio positions in Q2 2025 and 22 closed out, a net change of +6 holders.
  • The largest Third Harmonic Bio buyer in Q2 2025 was Schonfeld Strategic Advisors, an estimated $3.69M added.
  • The largest Third Harmonic Bio seller in Q2 2025 was BVF Inc, an estimated $8.23M sold.

Based on aggregated 13F filings for Q2 2025.